Biopharmaceutical company MindMed has announced the first topline data from a novel Phase 2 trial testing high doses of LSD as a treatment for anxiety. The results indicate one to two LSD sessions can ...
Holding company Blackhawk Growth Corp.BLRZF's subsidiary company MindBio Therapeutics Pty Ltd shared the positive data gathered from its Phase 1 clinical trials microdosing LSD formulation in 80 ...
An incredible, first-of-its-kind trial testing the pain-killing properties of LSD microdoses has delivered the compelling suggestion that tiny, non-psychedelic doses of this infamous drug could serve ...
LSD has shown promise for treating conditions like depression, but it might not do much for ADHD. © cybermagician via Shutterstock LSD can do a lot of things, but ...
The magical and potent hallucinogen lysergic acid diethylamide (LSD) may have a new, clinically significant medical benefit: getting sleep. A new study, entitled “LSD Increases Sleep Duration the ...
Share on Pinterest The use of psychedelic drugs such as LSD in mental health treatment is at the forefront of clinical research. Lyuba Burakova/Stocksy Psychedelic compounds have gained increased ...
By the end of the six weeks, both the LSD and placebo groups had shown significant reductions in ADHD symptoms. On the primary measure, symptoms improved by an average of 7.1 points in the LSD group ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback